These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 20143199)

  • 1. Dopamine system dysregulation by the ventral subiculum as the common pathophysiological basis for schizophrenia psychosis, psychostimulant abuse, and stress.
    Grace AA
    Neurotox Res; 2010 Nov; 18(3-4):367-76. PubMed ID: 20143199
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hippocampal dysfunction and disruption of dopamine system regulation in an animal model of schizophrenia.
    Lodge DJ; Grace AA
    Neurotox Res; 2008 Oct; 14(2-3):97-104. PubMed ID: 19073417
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aberrant hippocampal activity underlies the dopamine dysregulation in an animal model of schizophrenia.
    Lodge DJ; Grace AA
    J Neurosci; 2007 Oct; 27(42):11424-30. PubMed ID: 17942737
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aversive stimuli alter ventral tegmental area dopamine neuron activity via a common action in the ventral hippocampus.
    Valenti O; Lodge DJ; Grace AA
    J Neurosci; 2011 Mar; 31(11):4280-9. PubMed ID: 21411669
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The hippocampus modulates dopamine neuron responsivity by regulating the intensity of phasic neuron activation.
    Lodge DJ; Grace AA
    Neuropsychopharmacology; 2006 Jul; 31(7):1356-61. PubMed ID: 16319915
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Developmental pathology, dopamine, stress and schizophrenia.
    Lodge DJ; Grace AA
    Int J Dev Neurosci; 2011 May; 29(3):207-13. PubMed ID: 20727962
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stress, glucocorticoids, and mesencephalic dopaminergic neurons: a pathophysiological chain determining vulnerability to psychostimulant abuse.
    Piazza PV; Marinelli M; Rougé-Pont F; Deroche V; Maccari S; Simon H; Le Moal M
    NIDA Res Monogr; 1996; 163():277-99. PubMed ID: 8809864
    [No Abstract]   [Full Text] [Related]  

  • 8. A fundamental role for hippocampal parvalbumin in the dopamine hyperfunction associated with schizophrenia.
    Boley AM; Perez SM; Lodge DJ
    Schizophr Res; 2014 Aug; 157(1-3):238-43. PubMed ID: 24888524
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic social defeat stress-induced enhancement of T-type calcium channels increases burst-firing neurons in the ventral subiculum.
    Lee S; Lee C; Woo C; Kang SJ; Shin KS
    Biochem Biophys Res Commun; 2019 Jan; 508(4):1182-1187. PubMed ID: 30554654
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Corticosterone in the ventral hippocampus differentially alters accumbal dopamine output in drug-naïve and amphetamine-withdrawn rats.
    Bray B; Clement KA; Bachmeier D; Weber MA; Forster GL
    Neuropharmacology; 2020 Mar; 165():107924. PubMed ID: 31881169
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ventral subiculum regulates hypothalamo-pituitary-adrenocortical and behavioural responses to cognitive stressors.
    Herman JP; Dolgas CM; Carlson SL
    Neuroscience; 1998 Sep; 86(2):449-59. PubMed ID: 9881860
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optogenetic induction of the schizophrenia-related endophenotype of ventral hippocampal hyperactivity causes rodent correlates of positive and cognitive symptoms.
    Wolff AR; Bygrave AM; Sanderson DJ; Boyden ES; Bannerman DM; Kullmann DM; Kätzel D
    Sci Rep; 2018 Aug; 8(1):12871. PubMed ID: 30150758
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hippocampus, amygdala, and stress: interacting systems that affect susceptibility to addiction.
    Belujon P; Grace AA
    Ann N Y Acad Sci; 2011 Jan; 1216():114-21. PubMed ID: 21272015
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Role of Genes, Stress, and Dopamine in the Development of Schizophrenia.
    Howes OD; McCutcheon R; Owen MJ; Murray RM
    Biol Psychiatry; 2017 Jan; 81(1):9-20. PubMed ID: 27720198
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dopamine system dysregulation by the hippocampus: implications for the pathophysiology and treatment of schizophrenia.
    Grace AA
    Neuropharmacology; 2012 Mar; 62(3):1342-8. PubMed ID: 21621548
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dopaminergic mechanisms in idiopathic and drug-induced psychoses.
    Lieberman JA; Kinon BJ; Loebel AD
    Schizophr Bull; 1990; 16(1):97-110. PubMed ID: 2185538
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Psychostimulant-induced plasticity of intrinsic neuronal excitability in ventral subiculum.
    Cooper DC; Moore SJ; Staff NP; Spruston N
    J Neurosci; 2003 Oct; 23(30):9937-46. PubMed ID: 14586024
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The dopamine hypothesis of schizophrenia: limbic interactions with serotonin and norepinephrine.
    Joyce JN
    Psychopharmacology (Berl); 1993; 112(1 Suppl):S16-34. PubMed ID: 7831438
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of firing of dopaminergic neurons and control of goal-directed behaviors.
    Grace AA; Floresco SB; Goto Y; Lodge DJ
    Trends Neurosci; 2007 May; 30(5):220-7. PubMed ID: 17400299
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increasing endocannabinoid levels in the ventral pallidum restore aberrant dopamine neuron activity in the subchronic PCP rodent model of schizophrenia.
    Aguilar DD; Chen L; Lodge DJ
    Int J Neuropsychopharmacol; 2014 Oct; 18(1):. PubMed ID: 25539511
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.